| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 12/20/2001 | CA2412217A1 Hiv-1 reporter viruses and their use in assaying anti-viral compounds |
| 12/20/2001 | CA2411908A1 Detection of mycosphaerella using the polymerase chain reaction |
| 12/20/2001 | CA2411740A1 Improved combinatorial libraries by recombination in yeast and analysis method |
| 12/20/2001 | CA2411401A1 Means and methods for monitoring antiretroviral therapy and guiding therapeutic decisions in the treatment of hiv/aids |
| 12/20/2001 | CA2411278A1 Compositions and methods for the therapy and diagnosis of colon cancer |
| 12/20/2001 | CA2411179A1 Method for increasing luminescence assay sensitivity |
| 12/20/2001 | CA2411036A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues |
| 12/20/2001 | CA2410659A1 Transgenic mice containing nuclear hormone receptor gene disruptions |
| 12/20/2001 | CA2410610A1 Human kinases |
| 12/20/2001 | CA2410532A1 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro |
| 12/20/2001 | CA2410229A1 Vaccine for congenital tremors in pigs |
| 12/20/2001 | CA2409973A1 Reverse detection for identification and/or quantification of nucleotide target sequences on biochips |
| 12/20/2001 | CA2409400A1 Dielectrically-engineered microparticles |
| 12/20/2001 | CA2409315A1 Protein phosphatases |
| 12/20/2001 | CA2351275A1 Use of polypeptides or nucleic acids for the diagnosis or treatment of skin disorders and wound healing and for the identification of pharmacologically active substances |
| 12/19/2001 | EP1164370A1 Method of determining substrate, and biosensor |
| 12/19/2001 | EP1164203A2 DNA Diagnostics based on mass spectrometry |
| 12/19/2001 | EP1164202A1 Mismatch-recognizing molecules |
| 12/19/2001 | EP1164201A1 Reverse detection for identification and/or quantification of nucleotide target sequences on biochips |
| 12/19/2001 | EP1164200A2 Method and device for drug-drug interaction testing sample preparation |
| 12/19/2001 | EP1164199A1 ENZYMATIC FLUORIMETRIC ASSAY OF cAMP AND ADENYLATE CYCLASE |
| 12/19/2001 | EP1164198A1 Method for screening anticancer agent |
| 12/19/2001 | EP1164186A2 Method for investigating membrane enclosed biocompartments |
| 12/19/2001 | EP1163527A1 Diagnosis of lysosomal storage disorders using saposins and other markers |
| 12/19/2001 | EP1163526A2 High throughput assay based on the use of a polypeptide binding pair |
| 12/19/2001 | EP1163524A2 Methods of screening for colorectal cancer modulators |
| 12/19/2001 | EP1163522A1 Method for detecting superantigen activity in a biological sample |
| 12/19/2001 | EP1163520A1 Porous coatings bearing ligand arrays |
| 12/19/2001 | EP1163519A1 Protein isolation and analysis |
| 12/19/2001 | EP1163517A2 Method of screening candidate compounds for susceptibility to biliary excretion |
| 12/19/2001 | EP1163515A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 12/19/2001 | EP1163514A1 AN $i(IN VIVO) AND $i(IN VITRO) MODEL FOR CUTANEOUS PHOTOAGING AND OXIDATIVE DAMAGE |
| 12/19/2001 | EP1163374A2 Arrays of organic compounds attached to surfaces |
| 12/19/2001 | EP1163371A2 Methods for purifying dna using immobilized capture probes |
| 12/19/2001 | EP1163370A2 Transposon-based genetic marker |
| 12/19/2001 | EP1163369A1 Sequencing by incorporation |
| 12/19/2001 | EP1163368A1 Enzymatically catalysed signal amplification |
| 12/19/2001 | EP1163367A2 Analysis of differential gene expression |
| 12/19/2001 | EP1163365A1 Diagnosis and therapy of premature ovarian failure |
| 12/19/2001 | EP1163364A1 Screening method involving mgdg synthase |
| 12/19/2001 | EP1163363A2 Compositions and methods for monitoring the modification of natural binding partners |
| 12/19/2001 | EP1163362A1 Device and method for microbial susceptibility testing |
| 12/19/2001 | EP1163361A2 A diagnostic test |
| 12/19/2001 | EP1163360A2 Composition and device for detecting leukocytes in urine |
| 12/19/2001 | EP1163359A1 Method for generating transcriptionally active dna fragments |
| 12/19/2001 | EP1163357A1 Primers-attached vector elongation (pave): a 5'-directed cdna cloning strategy |
| 12/19/2001 | EP1163345A1 Fungal beta-tubulin genes |
| 12/19/2001 | EP1163344A1 Hyphal growth in fungi |
| 12/19/2001 | EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/19/2001 | EP1163340A1 Compositions and methods for the modification of gene expression |
| 12/19/2001 | EP1163338A2 HUMAN MESENCHYMAL DNAs AND EXPRESSION PRODUCTS |
| 12/19/2001 | EP1163337A2 Vascular adhesion molecules and modulation of their function |
| 12/19/2001 | EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |
| 12/19/2001 | EP1163332A1 48 human secreted proteins |
| 12/19/2001 | EP1163331A1 50 human secreted proteins |
| 12/19/2001 | EP1163327A1 Human protein kinase b gamma polypeptides and a method for disrupting protein kinase b gamma in a non-human |
| 12/19/2001 | EP1163269A1 ISOFORMS OF MOUSE SEROTONIN 5-HT2c RECEPTOR |
| 12/19/2001 | EP1163267A1 47 human secreted proteins |
| 12/19/2001 | EP1163266A2 Barley gene for thioredoxin and nadp-thioredoxin reductase |
| 12/19/2001 | EP1163255A1 50 human secreted proteins |
| 12/19/2001 | EP1163252A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene |
| 12/19/2001 | EP1163052A1 Manipulation of microparticles in microfluidic systems |
| 12/19/2001 | EP1162993A2 Use of casb616 polypeptides and polynucleotides for cancer treatment |
| 12/19/2001 | EP1162961A2 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
| 12/19/2001 | EP1162886A1 System and method for evaluating agents which prevent oxidative damage |
| 12/19/2001 | EP1114177A4 Assay member and method for its manufacture |
| 12/19/2001 | EP1075551B1 Method for non-radioactive detection of membrane-bonded nucleic acids and test kit |
| 12/19/2001 | EP1051622A4 PAI-2 AND t-PA AS DIAGNOSTIC MARKERS OF PERIODONTAL DISEASE |
| 12/19/2001 | EP0963250B1 Improvements in thermal cycler for pcr |
| 12/19/2001 | EP0948639A4 Identification of blast cells in a leukocyte cell preparation |
| 12/19/2001 | EP0935605A4 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 12/19/2001 | EP0871777A4 Electronically-solid-phase assay biomolecules |
| 12/19/2001 | EP0864000A4 Method of determining the sequence of nucleic acids employing solid-phase particles carrying transponders |
| 12/19/2001 | EP0775215B1 Chemiluminescence assays based on indoxyl substrates or thioindoxyl substrates |
| 12/19/2001 | EP0727045B1 Self-addressable self-assembling microelectronic systems and devices for molecular biological analysis and diagnostics |
| 12/19/2001 | EP0623215B1 Methods and compositions for diagnosing cat scratch disease and bacillary angiomatosis |
| 12/19/2001 | EP0528820B2 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase |
| 12/19/2001 | CN1327536A 葡萄糖传感器 The glucose sensor |
| 12/19/2001 | CN1327481A Automatic DNA purificating apparatus |
| 12/19/2001 | CN1327479A Novel DNA fragment elevating gene expression dose |
| 12/19/2001 | CN1327449A Human cervical cancer 1 protooncogene and protein encoded therein |
| 12/19/2001 | CN1327070A Diagnosis method based on nucleic acid having catalytic activity |
| 12/19/2001 | CN1327066A New polypeptide-human ATP dependent membrane conjugated zinc proteinase 10.45 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1327064A New polypeptide-human protein phosphatase 12.98 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1327063A New polypeptide-human protein phosphatase 11.66 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1327062A New polypeptide-human protein phoshatase 24.53 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1327061A New polypeptide-human protein phosphatase 8.8 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1327060A New polypeptide-human striatum corpura enrichment phosphatase 12.43 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1327059A New polypeptide-pyrophosphatic acid hydrolase 33 and polynucleotide for encoding such polypeptide |
| 12/19/2001 | CN1327054A New polypeptide-human quasi-Nedd-4 ubiquinone protein ligase WWP28.8 and polynucleotide fo encoding such polypeptide |
| 12/19/2001 | CN1327048A A strain of recombined broad spectrum bacillus thuringiensis |
| 12/19/2001 | CN1326970A New human protein kinase and its coding sequence |
| 12/19/2001 | CN1076397C Process for preparing mycobacterium primers and probes |
| 12/18/2001 | US6331622 Processes for preparation of 9, 11-epoxy steroids and intermediates useful therein |
| 12/18/2001 | US6331618 For analytical methods such as gel electrophoresis, high-performance liquid chromatography, primer extension reactions, polymerase chain reaction (pcr), mass spectroscopy, nuclear magnetic resonance (nmr) and x-ray crystallization |
| 12/18/2001 | US6331615 Nucleic acid molecule encoding heavy or light chain of an antibody which specifically recognizes a protein specifically recognized by monoclonal antibody 5c8 (anti-CD40 ligand) |
| 12/18/2001 | US6331613 Nucleotide sequences coding protein associated with cytokine activity; for use in treating allergies, autoimmune diseases and acquired immune deficiency syndrome; for preventing cell differentiation; for activating tissue regeneration |
| 12/18/2001 | US6331542 Protease inhibitors |
| 12/18/2001 | US6331441 For high throughput analysis of multiple analytes in complex mixtures of sample substances, combinatorial analysis |
| 12/18/2001 | US6331433 Human T cell leukemia cell line designated D1.1 |